ACI Clinical’s Executive Leadership remains deeply involved in several public-private thought leadership partnerships with regulatory agencies that focus on shaping Endpoint Adjudication, Safety Assessment Committee and Data Monitoring Committee best practices. Here’s a sampling of our thought leadership activities:
ACI Clinical’s CEO, Dr. Jonathan Seltzer, co-chaired an Adjudication Think Tank in 2013, sponsored by CSRC/FDA, moderated a Device Adjudication Think Tank in 2016, and is currently working on future scientific programs for the CSRC
Involved in a Data Monitoring Committees (DMCs) project that is intended to guide the revision of the 2006 FDA Guidance on the Establishment and Operation of Data Monitoring Committees
ACI Clinical has been a CDISC Registered Solutions Provider for over a decade.